Pediatric glioma recurrence is a pressing concern in the realm of childhood brain cancer, as the unpredictable nature of these tumors poses significant challenges for pediatric patients and their families.Recent advancements, particularly through the use of artificial intelligence, have sparked hope in accurately predicting the risk of relapse.